News
October 5, 2016 — Medtronic said two previously communicated global voluntary recalls related to the HeartWare ...
October 05, 2016
Technology | Contrast Media
GE Healthcare announced that the U.S. Food and Drug Administration (FDA) has approved a label change for the ultrasound contrast agent Optison (Perflutren protein-Type A Microspheres Injectable Suspension, USP). The FDA removed the contraindications for use in patients with cardiac shunts and for administration by intra-arterial injection. Both contraindications have been revised and moved to the WARNINGS AND PRECAUTIONS section (5.3 : Systemic Embolization) of the Full Prescribing Information.
October 04, 2016
News | Heart Valve Technology
October 4, 2016 — Xeltis recently announced that three pediatric patients have been successfully implanted with the ...
October 04, 2016Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News | Cardiovascular Business
SpringBoard Healthcare is now taking responses for its nationwide wage survey of nurses, technicians and specialists working in cardiac catheterization, electrophysiology and interventional radiology labs. The survey is designed to gather comprehensive insight into the salaries and wages of employees in that sector. The results, based on data from thousands of participants, highlight salary and wage differences by job type, experience, facility type, credentials, and state and region.
October 04, 2016
Videos | Congenital Heart
This video, provided by Xeltis, demonstrates the world’s first bioresorbable heart valve enabling cardiovascular ...
October 04, 2016
News | Heart Valve Technology
Keystone Heart Ltd. announced data recently published in the American Journal of Cardiology demonstrating new brain lesions in 94 percent of patients undergoing transcatheter aortic valve replacement (TAVR). The lesions were detected by diffusion weighted magnetic resonance imaging (DWI-MRI) (n=34) prior to hospital discharge.
October 03, 2016Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Feature | Dave Fornell
October 3, 2016 — Here is the list of the top 15 most popular pieces of content on the Diagnostic and Interventional ...
October 03, 2016
Feature | Val Kapitula, RT(R), PMP, CIIP
Cardiovascular information and imaging systems (CVIS) have existed for many years in the dedicated sub-specialty areas ...
September 29, 2016
News | Embolic Protection Devices
Keystone Heart Ltd. recently announced the safety and efficacy of the TriGuard Cerebral Embolic Protection device during transcatheter aortic valve replacement (TAVR), according to preliminary findings discussed at the PCR London Valves 2016 Conference. The findings were drawn from real-world experience of 51 patients.
September 29, 2016Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Feature | Heart Failure | Abha Mishra
New cardiovascular device therapies for atrial fibrillation (AF) and heart failure (HF) are rapidly evolving with the ...
September 29, 2016News | Cardiac Diagnostics
Increasing stomach fat – especially the “hidden fat” in your abdomen – is associated with newly identified and worsening heart disease risk factors, according to a study published recently in the Journal of the American College of Cardiology. These adverse changes in cardiovascular risk were evident over a relatively short period of time and persisted even after accounting for changes in body mass index (BMI) and waist circumference, two commonly used methods to estimate whether someone is a healthy weight or not.
September 28, 2016
News | Thrombectomy Devices
Neuravi recently announced Conformité Européenne (CE) Mark approval and launch of the company’s newly available enhancements to the EmboTrap stent retriever platform, the EmboTrap II Revascularization Device.
September 28, 2016Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Feature | Angiography | Tom Watson, RCVT, Clinical Analyst, MD Buyline
(Editor's note: links to newer information and video links from recent conferences were added to this article in ...
September 28, 2016
News | Cardio-oncology
September 28, 2016 — In a recent study, a Yale Cancer Center team determined that men who received hormonal therapy for ...
September 28, 2016
Feature | Sudden Cardiac Arrest | Allied Market Research
Automated external defibrillators (AED) are portable and lightweight devices used to deliver an electric shock through ...
September 28, 2016© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now